Welcome to LookChem.com Sign In|Join Free
  • or
(+)-9-Norartemisinin, 9-n-butylis a chemical compound derived from artemisinin, a natural product with potent antimalarial properties. This derivative features a butyl group attached to the 9th carbon atom and has been studied for its potential as an antimalarial agent. Structurally related to artemisinin and its derivatives, (+)-9-Norartemisinin, 9-n-butylhas shown promising results in inhibiting the growth of malaria parasites and, in some cases, demonstrated improved efficacy compared to other artemisinin derivatives. Its antimalarial activities position it as a potential candidate for further drug development and research in combating malaria.

154698-10-9

Post Buying Request

154698-10-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

154698-10-9 Usage

Uses

Used in Pharmaceutical Industry:
(+)-9-Norartemisinin, 9-n-butylis used as an antimalarial agent for its ability to inhibit the growth of malaria parasites. Research has indicated that it may offer improved efficacy over other artemisinin derivatives, making it a valuable asset in the ongoing fight against malaria. Its potential for further drug development and research underscores its importance in the pharmaceutical sector for creating new treatments to combat this global health issue.

Check Digit Verification of cas no

The CAS Registry Mumber 154698-10-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,4,6,9 and 8 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 154698-10:
(8*1)+(7*5)+(6*4)+(5*6)+(4*9)+(3*8)+(2*1)+(1*0)=159
159 % 10 = 9
So 154698-10-9 is a valid CAS Registry Number.

154698-10-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name (+)-octahydro-9β-butyl-3,6α-dimethyl-3,12-epoxy-12H-pyrano<4,3-j>-1,2-benzodioxepin-10(3H)-one

1.2 Other means of identification

Product number -
Other names (+)-octahydro-9β-butyl-3,6α-dimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin-10(3H)-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:154698-10-9 SDS

154698-10-9Downstream Products

154698-10-9Relevant academic research and scientific papers

C-16 artemisinin derivatives and their antimalarial and cytotoxic activities: Syntheses of artemisinin monomers, dimers, trimers, and tetramers by nucleophilic additions to artemisitene

Ekthawatchai,Kamchonwongpaisan,Kongsaeree,Tarnchompoo,Thebtaranonth,Yuthavong

, p. 4688 - 4695 (2001)

Nucleophilic additions of lithium keto and ester enolates and mono- and bifunctional Grgnard reagents to artemisitene provided C-16-derived artemisinin monomers, dmers, trimers, and tetramers whose antimalarial and cytotoxic have been evaluated.

Structure-activity relationships of the antimalarial agent artemisinin. 7. Direct modification of (+)-artemisinin and in vivo antimalarial screening of new, potential preclinical antimalarial candidates

Avery, Mitchell A.,Alvim-Gaston, Maria,Vroman, Jeffrey A.,Wu, Baogen,Ager, Arba,Peters, Wallace,Robinson, Brian L.,Charman, William

, p. 4321 - 4335 (2007/10/03)

On the basis of earlier reported quantitative structure-activity relationship studies, a series of 9β-16-(arylalkyl)-10-deoxoartemisinins were proposed for synthesis. Several of the new compounds 7 and 10-14 were synthesized employing the key synthetic intermediate 23. In a second approach, the natural product (+)-artemisinic acid was utilized as an acceptor for conjugate addition, and the resultant homologated acids were subjected to singlet oxygenation and acid treatment to provide artemisinin analogues. Under a new approach, we developed a one step reaction for the interconversion of artemisinin 1 into artemisitene 22 that did not employ selenium-based reagents and found that 2-arylethyliodides would undergo facile radical-induced conjugate addition to the exomethylene lactone of 22 in good yield. The lactone carbonyls were removed sequentially by diisobutylaluminum hydride reduction followed directly by a second reduction (BF3-etherate/Et3SiH) to afford the desired corresponding pyrans. Six additional halogen-substituted aromatic side chains were installed via 22 furnishing the bioassay candidates 15-20. The analogues were examined for in vitro antimalarial activity in the W-2 and D-6 clones of Plasmodium falciparum and were additionally tested in vivo in Plasmodium berghei- and/or Plasmodium yoelii-infected mice. Several of the compounds emerged as highly potent orally active candidates without obvious toxicity. Of these, two were chosen for pharmacokinetic evaluation, 14 and 17.

Structure-Activity Relationships of the Antimalarial Agent Artemisinin. 1. Synthesis and Comparative Molecular Field Analysis of C-9 Analogs of Artemisinin and 10-Deoxoartemisinin

Avery, Mitchell A.,Gao, Fenglan,Chong, Wesley K. M.,Mehrotra, Sanjiv,Milhous, Wilbur K.

, p. 4264 - 4275 (2007/10/02)

A series of C-9 β-substituted artemisinin analogs (2-21) were synthesized via dianion alkylation of the total synthetic intermediate 57 followed by subsequent ozonolysis/acidification, or by alkylation of the enolate derived from (+)-9-desmethylartemisini

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 154698-10-9